Article

Investigating CYP2C9*3 Polymorphisms in Patients with Neuropsychological Disorders through Pharmacogenomics Testing

2025-12-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The CYP2C9 gene encodes the cytochrome P450 2C9 enzyme, which plays a key role in metabolizing various drugs. Genetic polymorphisms in CYP2C9 may alter enzyme activity, influencing drug metabolism and treatment response. This study investigates the distribution of CYP2C9*3 polymorphisms and predicted phenotypes in patients with neuropsychological disorders, including bipolar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c226d373-57d8-502f-b64e-6b0c37f73c12
DOI: 10.64898/2025.12.03.25340647

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Investigating CYP2C9*3 Polymorphisms in Patients with Neuropsychological Disorders through Pharmacogenomics TestingDOI 10.64898/2025.12.03.25340647Read

Towards the implementation ofCYP2D6andCYP2C19genotypes in clinical practice: Update and report from a pharmacogenetic service clinicSemantic proximity Read

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapySemantic proximity Read

Distribution of pharmacogene allele and phenotype frequencies in Brazilian psychiatric patients.Semantic proximity Read

Psychiatric pharmacogenomic testing in clinical practiceSemantic proximity Read

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studiesSemantic proximity Read

Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population.Semantic proximity Read

Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).Semantic proximity Read

Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression—Arguments for Preemptive TestingSemantic proximity Read

The Pharmacogenetics of Treatment with QuetiapineSemantic proximity Read

A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder.Semantic proximity Read

Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.Semantic proximity Read

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.Semantic proximity Read